Humana — Apr 30, 2025 release
Fiscal 2025 first-quarter results · 8-K Item 2.02 · Exhibit 99.1 · 0000049071-25-000021
Showing in the filing
CenterWell segment income from operations - GAAP
“$1.0 billion to $1.5 billion”
Period
FY2025
Measure
GAAP-tied
Source
Guidance table
All guidance in this release · 22
GAAP EPS for FY2025
“approximately $14.68”
Insurance segment benefit ratio for FY2025
“90.1 percent to 90.5 percent”
Adjusted FY 2025 EPS for FY2025
“approximately $16.25”
Diluted earnings per share (EPS) - Adjusted … for FY2025
“approximately $16.25”
Diluted earnings per common share (EPS) GAAP for FY2025
“approximately $14.68 (previously approximately $15.88)”
Diluted earnings per share (EPS) - GAAP for FY2025
“approximately $14.68”
Total Revenues Consolidated - GAAP for FY2025
“$126 billion to $128 billion”
Total Revenues Insurance segment - GAAP for FY2025
“$121 billion to $123 billion”
Total Revenues CenterWell segment - GAAP for FY2025
“$20.5 billion to $21.5 billion”
Change in year-end medical membership - Indi… for FY2025
“Decline of approximately 550,000”
Individual Medicare Advantage annual members… for FY2025
“approximately 550,000”
Change in year-end medical membership - Grou… for FY2025
“Relatively flat”
Change in year-end medical membership - Medi… for FY2025
“Growth of approximately 200,000”
Change in year-end medical membership - Stat… for FY2025
“Growth within 175,000 to 250,000 range”
Operating Cost Ratio - Consolidated GAAP for FY2025
“11.3% to 11.7%”
Segment Results - Insurance segment income f… for FY2025
“$1.5 billion to $2.0 billion”
CenterWell segment income from operations - … for FY2025
“$1.0 billion to $1.5 billion”
CenterWell segment income from operations - … for FY2025
“$1.2 billion to $1.7 billion”
Effective Tax Rate - GAAP for FY2025
“approximately 25.0%”
Weighted Avg. Share Count for Diluted EPS for FY2025
“approximately 121.5 million”
Cash flows from operations - GAAP for FY2025
“$2.4 billion to $2.9 billion”
Capital expenditures for FY2025
“approximately $650 million”
Exhibit 99.1 · the passage around this item
… earlier in the release
Segment Results Insurance segment income from operations GAAP: $1.5 billion to $2.0 billion CenterWell segment Non-GAAP income from operations excludes the projected impact of segment depreciation and amortization. CenterWell segment income from operations GAAP: $1.0 billion to $1.5 billion Non-GAAP: $1.2 billion to $1.7 billion Effective Tax Rate GAAP: approximately 25.0% Weighted Avg. Share Count for Diluted EPS approximately 121.5 million Cash flows from operations GAAP: $2.4 billion to $2.9 billion Capital expenditures approximately $650 million 12 Humana Inc. Statistical Schedules and Supplementary Information 1Q25 Earnings Release S-1 Humana Inc. Statistical Schedules and Supplementary Information 1Q25 Earnings Release (S-3) Summary of Results - Consolidated and Segment - Quarter (S-4) Consolidated Statements of Income - Quarter (S-5) Consolidated Balance Sheets (S-6) Consolidated Statements of Cash Flows - YTD (S-7) - (S-8) Consolidating Statements of Income - Quarter (S-9) Membership Detail (S-10) Premiums and Services Revenue Detail (S-11) - (S-13) CenterWell Segment - Pharmacy Solutions, Primary Care, & Home Solutions (S-14) Footnotes S-2 Humana Inc. Summary of Results ($ in millions, except per share amounts) 1Q25 (a) 1Q24 (a) CONSOLIDATED Revenues $32,112 $29,611 Revenues - Adjusted (non-GAAP) $32,112 $29,332 Pretax results $1,691 $1,014 Pretax results - Adjusted (non-GAAP) $1,893 $1,191 EPS $10.30 $6.11 EPS - Adjusted (non-GAAP) $11.58 $7.23 Benefit rati
later in the release …
the item shown at left
other guidance in this release
Text is the filed exhibit, verbatim.